—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Integra LifeSciences Holdings (IART) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for IART, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 1.74 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How IART has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.74 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Integra LifeSciences Holdings moved 1.74% on average · correlation 0.27 · higher than 98% of US names
  • Beta, last 3 months 2.11 more rate-sensitive lately than over the year
  • On the 10 worst bond days −3.12% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +2.25% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against IART on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Integra LifeSciences Holdings

IART in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Integra LifeSciences makes medical devices for neurosurgery, ear-nose-throat care and wound treatment, sold through two divisions, Codman Specialty Surgical and Tissue Technologies. Codman covers tools for brain and spine surgery, such as monitoring equipment and dural repair products, plus surgical headlamps and instruments. Tissue Technologies covers skin substitutes and tissue repair materials used for burns, diabetic ulcers, hernia support and nerve repair. It sells to hospitals, surgery centres and clinicians in the United States and abroad, and is based in Princeton, New Jersey.
Where it sits in the stack
Integra LifeSciences holds no seat in Rubin, our AI build-out index; it sits in the Healthcare sector, within the medical-devices sleeve of our broader universe, and stops there.
Who it is priced against
Closelooknet's peer group for Integra LifeSciences is not yet defined; the comparison the market draws is with Medtronic, a broader medical-device maker active in similar surgical and neuro-technology markets.
Why Closelooknet tracks it
Integra LifeSciences holds a seat in the Russell 1000 but carries no Closelooknet score yet, and the diary has not quoted it in an edition to date.
What the diary watches
The diary watches how demand splits between the neurosurgery-focused Codman segment and the wound-care-focused Tissue Technologies segment as hospital capital spending shifts.

Integra LifeSciences Holdings (IART) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Integra LifeSciences Holdings (IART)?

Integra LifeSciences Holdings trades as IART on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is IART in a Closelooknet index?

Not currently — Integra LifeSciences Holdings is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does IART trade against its moving averages?

Pullback inside an uptrend stack: Trades -5.6% vs the 50-day and +15.1% vs the 200-day average, 21.3% below the 52-week high and +85.3% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Integra LifeSciences Holdings trade when bond yields rise?

Over the past year Integra LifeSciences Holdings had a beta of 1.74 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 98% of US names. On the 10 sessions in which long bonds fell most it moved −3.12% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Integra LifeSciences Holdings do?

Integra LifeSciences makes medical devices for neurosurgery, ear-nose-throat care and wound treatment, sold through two divisions, Codman Specialty Surgical and Tissue Technologies. Codman covers tools for brain and spine surgery, such as monitoring equipment and dural repair products, plus surgical headlamps and instruments. Tissue Technologies covers skin substitutes and tissue repair materials used for burns, diabetic ulcers, hernia support and nerve repair. Closelooknet's peer group for Integra LifeSciences is not yet defined; the comparison the market draws is with Medtronic, a broader medical-device maker active in similar surgical and neuro-technology markets.

Where does Integra LifeSciences Holdings sit in the AI build-out?

Integra LifeSciences holds no seat in Rubin, our AI build-out index; it sits in the Healthcare sector, within the medical-devices sleeve of our broader universe, and stops there. Integra LifeSciences holds a seat in the Russell 1000 but carries no Closelooknet score yet, and the diary has not quoted it in an edition to date.

What does this page show?

A live price chart with SMA overlays and drawing tools for IART, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.